Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04954664 · ClinicalTrials.gov registry record · NA
Ridge Augmentation Using Allograft Particles Hydrated With or Without Recombinant Human Platelet-Derived Growth Factor
A NA study of Bone Loss and Dental Implant, sponsored by University of Alabama at Birmingham.
- Recruiting
- Registry status
- NA
- Development phase
- 44
- Enrollment target
- 1
- Study location
NCT04954664 is a NA study of Bone Loss and Dental Implant that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 44 participants, below the 252-participant average among 16 other Bone Loss trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04954664, a NA study of Bone Loss and Dental Implant, is actively recruiting participants, sponsored by University of Alabama at Birmingham.
- RECRUITING
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will compare two techniques to achieve increase in ridge dimensions as a preparation for dental implants using a resorbable barrier membrane and bone particulate allogenic graft hydrated with saline or a growth factor called Recombinant Human Platelet-Derived Growth Factor (rhPDGF).
Conditions Studied
Interventions
- BIOLOGICAL Allograft particles hydrated with rhPDGF
- BIOLOGICAL Allograft particles hydrated in a conventional way with saline.
Study Locations (1)
Alabama
- Unversity of Alabama at Birmingham, School of Dentistry - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2021-08-11 |
| Est. Completion | 2027-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04954664
The ClinicalTrials.gov registry entry for NCT04954664 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 252-participant average among 16 other Bone Loss trials with a reported enrollment target (83% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Bone Loss appearing as the primary indexed condition, and to 2 interventions - of which Allograft particles hydrated with rhPDGF is the first listed.
NCT04954664 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.
Frequently Asked Questions
What is clinical trial NCT04954664 about?
NCT04954664 is a clinical study titled "Ridge Augmentation Using Allograft Particles Hydrated With or Without Recombinant Human Platelet-Derived Growth Factor". This study will compare two techniques to achieve increase in ridge dimensions as a preparation for dental implants using a resorbable barrier membrane and bone particulate allogenic graft hydrated with saline or a growth factor called Recombinant Human Platelet-Derived Growth Factor (rhPDGF).
What is the current status of trial NCT04954664?
This trial is currently recruiting. It is a NA study. The enrollment target is 44 participants. The study started on 2021-08-11. Estimated completion is 2027-12.
What conditions does trial NCT04954664 study?
This clinical trial studies the following conditions: Bone Loss, Dental Implant.
What interventions are being tested in trial NCT04954664?
The interventions under investigation include: Allograft particles hydrated with rhPDGF (BIOLOGICAL), Allograft particles hydrated in a conventional way with saline. (BIOLOGICAL).
Who is sponsoring clinical trial NCT04954664?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04954664 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bone Loss
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Lutein, Zeaxathin, and Fish Oil Supplementation
RECRUITING · NA
-
TRE: Microbiome, Metabolic Health and Bone
ACTIVE NOT RECRUITING · NA
-
Effects of Dietary Protein on Musculoskeletal Health During Calorie Deficiency
COMPLETED · NA
-
Bone, Exercise, Alendronate, and Caloric Restriction
RECRUITING · Phase 4
-
Skeletal Effects of Type 1 Diabetes on Low-Trauma Fracture Risk
RECRUITING
-
Bone in CKD Alkali Response (BICARb Pilot Trial)
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.